SCHEDULE 13G/A

Allogene Therapeutics Inc

Common Stock · CUSIP: 019770106

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• David D. Chang, M.D., Ph.D.

  Shares: 11,043,100.00 · Class: 5.0%

• Chang 2006 Family Trust

  Shares: 1,201,108.00 · Class: 0.5%

• JEC 2019 Trust

  Shares: 856,044.00 · Class: 0.4%

• RTC 2019 Trust

  Shares: 856,044.00 · Class: 0.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.